NCT00502138View on ClinicalTrials.gov

A Pilot Study of Continuous Subcutaneous Pramlintide Infusion Therapy in Patients With Type 1 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
IDDM
Interventions
DRUG

Continuous Pramlintide infusion

pramlintide injection, 9 mcg/hr plus 60 mcg premeal boluses

Trial Locations (1)

37403

University Diabetes & Endocrine Consultants, Chattanooga

Sponsors
All Listed Sponsors
collaborator

Amylin Pharmaceuticals, LLC.

INDUSTRY

lead

University Diabetes & Endocrine Consultants

OTHER